The agar dilution technique was used for determination of the antibiotic susceptibilities of 57 oral isolates and 2 nonoral isolates of Actinobacillus actinomycetemcomitans. Tetracycline, minocycline, and chloramphenicol inhibited more than 96% of the strains tested at a concentration of c2 Atg/ml; 89% of the strains were inhibited by 2 ug of carbenicillin per ml. The other antimicrobial agents tested were less active. Approximately 10% of the A. actinomycetemcomitans strains were resistant to ampicillin, erythromycin, and penicillin G at concentrations of 32 to 64 ug/ml. These data suggest that tetracycline and minocycline may be valuable drugs in the treatment ofA. actinomycetemcomitans infections.
Actinobacillus actinomycetemcomitans is a facultative, gram-negative bacterium of clinical importance. It has been isolated from actinomycosis (3, 5, 9, 10) , periodontitis (24; J. Slots, H. S. Reynolds, P. M. Lobbins, and R. J. Genco, J. Dent. Res., 59: 328, Special Issue A, Am. Assoc. Dent. Res., abstr. no. 244, 1980) , endocarditis (6, 16, 19, 27) , vertebral osteomyelitis (14), brain abscess (12) , thyroid gland abscess (4) , and urinary tract infection (26) . A. actinomycetemcomitans is often a constituent of mixed bacterial infections, but it can also be the sole infecting agent (25, 28) . A. actinomycetemcomitans can be a part of the indigenous oral microflora (9) , and the portal of entry of this organism is often assumed to be-the oral cavity and the upper respiratory tract.
A. actinomycetemcomitans strains vary in in vitro susceptibilities to penicillin, ampicillin, and other commonly used antibiotics (8, 11, 16) . Evidence that this diversity affects therapy is suggested by the fact that a given antibiotic has been effective in certain cases of A. actinomycetemcomitans infection, but has failed in others (2, 16, 27 
RESULTS
The in vitro antibacterial activities of the 15 antimicrobial agents tested against 59 isolates of A. actinomycetemcomitans are shown in Table  1 . A total offour antibiotics showed good activity at the peak serum concentrations that can be expected with frequently used clinical protocols (18) . All strains examined were inhibited by chloramphenicol at 2 ,ug/ml (achievable serum concentrations, 3 to 12 ,ug/ml), by minocycine at 4 ,ug/ml (achievable serum concentrations, 0.7 to 4.5 Ag/ml), by polymyxin B at 2 ,ig/ml (achievable serum concentrations, 2 to 8 ,ug/ml), and by tetracycline at 1 jg/ml (achievable serum concentrations by oral and intravenous routes of administration, respectively, 1 to 5 and 5 to 30 jig/ml). Carbenicillin also generally showed good activity, although about 10% of the test strains were not inhibited at 32,tg/ml.
The remaining 10 antimicrobial agents exhibited poor activity against A. actinomycetemcomitans. Only about 50% of the strains were inhibited by 4 jig of ampicillin, erythromycin, kanamycin, metronidazole, penicillin G, or vancomycin per ml, and several strains still exhibited resistance to these six antimicrobial agents at concentrations of 16 to 64 ,g/ml. The concentrations of clindamycin, lincomycin, and neomycin required to inhibit the growth of 50% of the total number of strains tested were 16 to 32 ,ug/ml. The test strains, including ATCC 29522, ATCC 29523, ATCC 29524, and Y4, which were recovered by nonselective culturing, exhibited a high level of resistance to bacitracin. In fact, no strains were inhibited at a concentration of bacitracin of 128 ,tg/ml.
The test for penicillinase showed no white color developing within 5 min after mixing of the starch solution with the penicillin-iodine-bacterium mixture, indicating that the strains tested did not produce penicillinase. DISCUSSION The recognition that A. actinomycetemcomitans infections are potentially more serious, more difficult to cure, and probably more common than previously realized stimulates interest in the susceptibility of the organism to antimicrobial agents. Of the commonly used antibiotics examined in this study, tetracycline, minocycline, and chloramphenicol, on a weight basis, were the most effective against A. actinomycetemcomitans; all of the organisms tested were susceptible to these antibiotics at a concentration of 4 ,ug/ml, whereas only about 50% were susceptible to ampicillin, erythromycin, and penicillin G at this concentration. The differ- Clindamycin   0  20  29  37  42  54  61  100  Erythromycin   2   29  34  47  53  63  90  98  100  Kanamycin  37  39  44  58  76  95  100  Lincomycin  0  12  19  32  65  93  100  Metronidazole  60  60  61  63  70  91  95  100  Minocycline  13  91  96  100  Neomycin  0  3  37  76  100   Penicilin G   0  31  47  54  71  71  78  93  100  Polymyxin B   47  68  100  Tetracycline  63  100  Vancomycin  16  37  47  47  49  49  56 96 100 a A total of 59 strains were tested. jig of tetracycline per ml inhibited 63% of the test strains, whereas ampicillin, erythromycin, and penicillin G were ineffective.
Previous reports of limited in vitro susceptibility testing of A. actinomycetemcomitans agree that this organism is susceptible to low concentrations of tetracycline (8, 11, 16, 22) and chloramphenicol (11, 16) and is frequently resistant to ampicillin (16) , erythromycin (8) , penicillin (8, 11, 16) , clindamycin (27) , lincomycin (20, 27) , and vancomycin (7) .
Despite favorable in vitro susceptibility data with tetracycline, there are only a few published results on the clinical efficacy of this antibiotic for A. actinomycetemcomitans infections. Bartlett et al. (1) reported that, in one actinomycosis patient treated with lincomycin, an infection due to A. actinomycetemcomitans resistant to lincomycin emerged and a cure was finally achieved with tetracycline. Page and King (16) described three patients with endocarditis who were cured after treatment with tetracycline.
Poor activity of penicillin against A. actinomycetemcomitans has been shown in actinomycosis-like infections which were not cured by penicillin due to the persistence of a penicillinresistant strain ofA. actinomycetemcomitans (9, 10, 25) . Cases of A. actinomycetemcomitans endocarditis which were not resolved by penicillin (2, 12, 15, 16) or which followed a tooth extraction with penicillin prophylaxis (13) have also been reported. A. actinomycetemcomitans endocarditis has responded favorably to combinations of antibiotics, including ampicillin, chloramphenicol, erythromycin, and streptomycin, but fatal cases in which such therapeutic regimes were used have also been reported (2, 16, 19, 27) , raising doubt concerning the universal efficacy of these combinations.
Since A. actinomycetemcomitans appears to play an important role in the progression of certain periodontal diseases (24) , the present in vitro susceptibility data showing that tetracycline and minocycine were highly active against A. actinomycetemcomitans will be useful in periodontal treatment considerations. It should also be noted that the concentration of tetracycline is 2-to 10-fold higher in the periodontal pocket area than in the blood (J. M. Gordon 
